文献速递乳房整形与再造

胸肌前乳房再造是否需要脱细胞真皮基质?系统评价与Meta分析

Do we need acellular dermal matrix in prepectoral breast reconstruction? A systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2023-09-21

该系统评价与Meta分析纳入4项研究共515例胸肌前乳房再造,比较使用与不使用脱细胞真皮基质(ADM)的并发症率,结果显示两组并发症率无显著差异,但无ADM组 outcomes 数据多反映血供良好的乳房切除皮瓣,作者认为应由术者根据具体临床情况决定是否使用ADM。

要点

  • 胸肌前乳房再造使用与不使用ADM的并发症率无显著差异。
  • 无ADM组的 outcomes 数据多反映血供良好的乳房切除皮瓣。
  • 作者认为应由术者根据具体临床情况决定是否使用ADM。

核心结论

  • 该Meta分析显示胸肌前乳房再造使用与不使用ADM的并发症率无差异,但无ADM组的 outcomes 数据多反映血供良好的乳房切除皮瓣,作者认为应由术者根据具体临床情况决定是否使用ADM。

研究设计与样本

  • 系统检索PubMed、EMBASE和Cochrane数据库,纳入比较胸肌前乳房再造使用与不使用ADM的研究,共4项研究515例再造。

主要发现

  • 短期并发症:再造失败ADM组1.2% vs 无ADM组2.8%,血清肿ADM组1.2% vs 无ADM组8.3%,血肿ADM组1.2% vs 无ADM组2.1%,感染ADM组4.7% vs 无ADM组4.2%,乳房切除皮瓣缺血和/或坏死ADM组2.4% vs 无ADM组5.2%。
  • 长期并发症:波纹征ADM组3.3% vs 无ADM组5.1%,包膜挛缩ADM组6.8% vs 无ADM组3.4%。
  • Meta分析显示使用与不使用ADM的队列间并发症率无显著差异。

临床怎么用

  • 作者认为应由术者根据具体临床情况决定是否在胸肌前乳房再造中使用ADM。

局限性

  • 比较胸肌前乳房再造使用与不使用ADM的研究仅限于小型单机构系列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acellular dermal matrices (ADMs) are commonly used in prepectoral breast reconstruction. However, ADM is associated with high cost and potentially infection and seroma. Comparative studies on prepectoral reconstruction with and without ADM are limited to small, single-institution series. The purpose of this study was to perform a meta-analysis of prepectoral reconstruction with and without ADM. A systematic literature review was performed to identify studies comparing prepectoral reconstruction with and without ADM using PubMed, EMBASE, and Cochrane databases. Pooled rates of patient demographics and outcomes were analyzed. Meta-analytic effect size estimates were calculated for reconstructive complications in studies comparing reconstruction with and without ADM. In total, 515 reconstructions from four studies were included. Most cases were nipple-sparing mastectomies and utilized tissue-expander reconstructions. Meta-analysis demonstrated no significant difference in the rate of complications between cohorts with and without ADM. Short-term complications included reconstructive failure (1.2% in ADM cohort and 2.8% in no-ADM), seroma (1.2% and 8.3%, respectively), hematoma (1.2% and 2.1%), infection (4.7% and 4.2%), and mastectomy flap ischemia and/or necrosis (2.4% and 5.2%). Long-term complications included rippling (3.3% in ADM and 5.1% in no-ADM cohorts) and capsular contracture (6.8% and 3.4%, respectively). This meta-analysis demonstrated no difference in the rate of complications between cases with and without ADM. However, the outcomes data from no-ADM reconstruction mostly reflect robust mastectomy flaps. Surgeon discretion as informed by specific clinical scenarios should guide decisions regarding the use of ADM in prepectoral breast reconstruction.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Nolan IT, Farajzadeh MM, Boyd CJ, et al. Do we need acellular dermal matrix in prepectoral breast reconstruction? A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 37793198. doi:10.1016/j.bjps.2023.09.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。